Sign in
ARTH Stock Price, Chart, Stats & News
Arch Therapeutics, Inc.
Save
Arch Therapeutics, Inc. (ARTH) does not currently pay a dividend.
444
Market cap
–
Current P/E
0.08x
Forward P/E
ARTH chart
Price history is unavailable
We don't have enough price data for ARTH to draw a chart yet.
About
Health care
Sector
Biotechnology
Industry
Arch Therapeutics, Inc., operating alongside its affiliated companies, functions as a biotechnology firm within the United States. The organization focuses on developing and commercializing products derived from its unique AC5 self-assembling technology platform. These innovations are engineered to arrest bleeding, control fluid leakage, and assist in wound care during surgical interventions, following trauma, throughout interventional medical procedures, or in cases of disease.
Similar securities
Based on sector and market capitalization
Report issue